Short Interest in NeuroMetrix, Inc. (NASDAQ:NURO) Decreases By 87.4%

NeuroMetrix, Inc. (NASDAQ:NURO) was the recipient of a large decline in short interest in January. As of January 15th, there was short interest totalling 2,700 shares, a decline of 87.4% from the December 31st total of 21,400 shares. Based on an average daily trading volume, of 21,200 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.2% of the company’s stock are sold short.

Wall Street Analysts Forecast Growth

Separately, StockNews.com began coverage on NeuroMetrix in a research note on Thursday, January 23rd. They set a “sell” rating for the company.

NeuroMetrix Price Performance

Shares of NASDAQ:NURO traded down $0.02 during midday trading on Tuesday, reaching $4.19. The company had a trading volume of 8,956 shares, compared to its average volume of 19,833. The stock has a market capitalization of $8.55 million, a P/E ratio of -0.91 and a beta of 2.20. The stock’s fifty day moving average price is $4.04 and its 200-day moving average price is $3.89. NeuroMetrix has a one year low of $2.66 and a one year high of $4.73.

NeuroMetrix (NASDAQ:NURO) last issued its earnings results on Tuesday, November 5th. The medical device company reported ($0.75) earnings per share (EPS) for the quarter. NeuroMetrix had a negative net margin of 203.71% and a negative return on equity of 42.56%. The company had revenue of $0.59 million during the quarter. During the same quarter in the previous year, the business posted ($1.66) EPS.

About NeuroMetrix

NeuroMetrix, Inc, a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use.